Bone Loss Drugs Increase Stroke Risk in Patients With Cancer
Older patients with cancer taking bisphosphonates for bone metastases are at modestly increased risk
Older patients with cancer taking bisphosphonates for bone metastases are at modestly increased risk for atrial fibrillation and stroke. According to a study published online in the Journal of Clinical Oncology, the absolute risk for these patients within 6 years of starting bisphosphonate treatment was approximately 8% for all supraventricular tachycardia events and 4% for stroke.
Articles in this issue
Net Guides: Melanoma
Net Guides: Bone Metastases
Yoga for Cancer Care
FDA Updates: March 7, 2011
The Future of Nursing
Net Guides: Liver Cancer
Net Guides: Carcinoma of Unknown Primary Orgin
Integrative Medicine and Cancer Treatment
Reimbursement for Nurse Navigation: It Can Be Done
Tools to Help Patients Navigate Their Treatment Path
John Theurer Cancer Center Opens New Comprehensive Facility
Bone Loss Drugs Increase Stroke Risk in Patients With Cancer
Oncology Community Facing Severe Drug Shortages
Net Guides: Oral Cancer
Related Videos
Related Content
